DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Camm AJ. et al.
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
Eur Heart J 2015; ehv466.
We do not assume any responsibility for the contents of the web pages of other providers.